<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00991029</url>
  </required_header>
  <id_info>
    <org_study_id>1U01S062835-01A1</org_study_id>
    <nct_id>NCT00991029</nct_id>
  </id_info>
  <brief_title>Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial</brief_title>
  <acronym>POINT</acronym>
  <official_title>Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Neurological Emergencies Treatment Trials Network (NETT)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Emmes Company, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused
      by focal brain, spinal cord, or retinal ischemia, without acute infarction. An ischemic
      stroke is a cerebral infarction. In POINT, eligibility is limited to brain TIAs and to minor
      ischemic strokes (with an NIH Stroke Scale [NIHSS] score less than or equal to 3).

      TIAs are common [25], and are often harbingers of disabling strokes. Approximately
      250,000-350,000 TIAs are diagnosed each year in the US. Given median survival of more than 8
      years [32], there are approximately 2.4 million TIA survivors. In a national survey, one in
      fifteen of those over 65 years old reported a history of TIA [33], which is equivalent to a
      prevalence of 2.3 million in older Americans. Based on the prevalence of undiagnosed
      transient neurological events, the true incidence of TIA may be twice as high as the rates of
      diagnosis [33]. Based on our review of the National Inpatient Sample for 1997-2003, there
      were an average of 200,000 hospital admissions for TIA each year, with annual charges
      climbing quickly in the period to $2.6 billion in 2003.

      Composite endpoint of new ischemic vascular events: ischemic stroke, myocardial infarction or
      ischemic vascular death at 90 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial, is a
      prospective, randomized, double-blind, multicenter trial with the primary null hypothesis
      that, in patients with TIA or minor ischemic stroke treated with aspirin 50-325 mg/day, there
      is no difference in the event-free survival at 90 days in those treated with clopidogrel (600
      mg loading dose then 75 mg/day) compared to placebo when subjects are randomized within 12
      hours of time last known free of new ischemic symptoms.

      Its primary objective is to determine whether clopidogrel 75 mg/day by mouth after a loading
      dose of 600 mg of clopidogrel is effective in preventing major ischemic vascular events
      (ischemic stroke, myocardial infarction, and ischemic vascular death) at 90 days when
      initiated within 12 hours of TIA or minor ischemic stroke onset in patients receiving aspirin
      50-325 mg/day (with a dose of 150-200 mg daily for 5 days followed by 75-100 mg daily
      strongly recommended).

      Patients over 18 years of age with high-risk TIA (defined as an ABCD2 score greater than or
      equal to 4) or minor ischemic stroke (with NIHSS less than or equal to 3) who can be treated
      within 12 hours of time last known free of new ischemic symptoms will be enrolled.

      Subjects will be randomized 1:1 (clopidogrel: placebo), controlling for clinical center. A
      study participant's eligibility will be determined by site personnel prior to accessing the
      Randomization Module in the WebDCUâ„¢, a web-enabled clinical trials management system that was
      developed by the NETT Statistics and Data Management Center (SDMC) at Medical University of
      South Carolina (MUSC).Qualified users will access the Randomization Interface and complete a
      protocol-specific eligibility checklist. If the Randomization Interface finds the patient to
      be eligible based on the information provided, a randomization number and a confirmatory
      e-mail are generated.

      Each subject is followed for 90 days from randomization; the trial will be completed in 7
      years.

      A total of 5,840 patients will be recruited. Recruitment will occur over 90 months, with a
      goal rate of 0.40 subjects/site/month for US sites, and a goal rate of 0.47
      subjects/site/month for OUS sites. Current participating sites can be found at:
      http://www.pointtrial.org/node/18.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The trial was halted by the DSMB.
  </why_stopped>
  <start_date type="Actual">May 28, 2010</start_date>
  <completion_date type="Actual">April 9, 2018</completion_date>
  <primary_completion_date type="Actual">April 9, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Hemorrhage</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Primary safety outcome: Number of Participants with major hemorrhage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ischemic Stroke</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Secondary efficacy outcome:Number of participants with Ischemic stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Secondary efficacy outcome: Number of participants with Myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death From Ischemic Vascular Causes</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemic or Hemorrhagic Stroke</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of Ischemic Stroke, Myocardial Infarction, Death From Ischemic Vascular Causes, or Major Hemorrhage</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hemorrhagic Stroke</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Other safety outcome: Number of participants with Hemorrhagic stroke</description>
  </other_outcome>
  <other_outcome>
    <measure>Symptomatic Intracerebral Hemorrhage</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage</description>
  </other_outcome>
  <other_outcome>
    <measure>Other Symptomatic Intracranial Hemorrhage</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage</description>
  </other_outcome>
  <other_outcome>
    <measure>Major Hemorrhage Other Than Intracranial Hemorrhage</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage</description>
  </other_outcome>
  <other_outcome>
    <measure>Minor Hemorrhage</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Other safety outcome:Number of Participants with Minor hemorrhage</description>
  </other_outcome>
  <other_outcome>
    <measure>Death From Any Cause</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Other safety outcome: Number of Participants with Death from any cause</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4881</enrollment>
  <condition>Ischemic Attack, Transient</condition>
  <arm_group>
    <arm_group_label>clopidogrel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients assigned to clopidogrel in addition to aspirin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients assigned to placebo in addition to aspirin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clopidogrel</intervention_name>
    <description>Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
    <arm_group_label>clopidogrel</arm_group_label>
    <other_name>Plavix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neurological deficit (based on history or exam) attributed to focal brain ischemia and
             EITHER:

               -  High risk TIA: Complete resolution of the deficit at the time of randomization
                  AND ABCD2 score of (greater than or equal to) 4 OR

               -  Minor ischemic stroke: residual deficit with NIHSS of (less than or equal to) 3
                  at the time of randomization

          -  Ability to randomize within 12 hours of time last known free of new ischemic symptoms.

          -  Head CT or MRI ruling out hemorrhage or other pathology, such as vascular
             malformation, tumor, or abscess, that could explain symptoms or contraindicate
             therapy.

          -  Ability to tolerate aspirin at a does of 50-325 mg/day.

        Exclusion Criteria

          -  Age &lt;18 years

          -  TIA symptoms limited to isolated numbness, isolated visual changes, or isolated
             dizziness/vertigo.

          -  In the judgment of the treating physician, a candidate for thrombolysis,
             endarterectomy or endovascular intervention, unless the subject declines both
             endarterectomy and endovascular intervention at the time of evaluation for
             eligibility.

          -  Receipt of any intravenous or intra-arterial thrombolysis within 1 week prior to index
             event.

          -  Gastrointestinal bleed or major surgery within 3 months prior to index event.

          -  History of nontraumatic intracranial hemorrhage.

          -  Clear indication for anticoagulation (e.g., warfarin, heparin) anticipated during the
             study period (atrial fibrillation, mechanical heart valve, deep venous thrombosis,
             pulmonary embolism, antiphospholipid antibody syndrome, hypercoagulable state).

          -  Qualifying ischemic event induced by angiography or surgery.

          -  Severe non-cardiovascular comorbidity with life expectancy &lt;3 months.

          -  Contraindication to clopidogrel or aspirin.

               -  Known allergy

               -  Severe renal (serum creatinine &gt;2 mg/dL or 176.8umol/L) or hepatic insufficiency
                  (prior or concurrent diagnosis, with International Normalized Ratio (INR)&gt;1.5 or
                  any resultant complication, such as variceal bleeding, encephalopathy, or
                  icterus)

               -  Hemostatic disorder or systemic bleeding in the past 3 months

               -  Current thrombocytopenia (platelet count &lt;100 x10^9/l) or neutropenia (&lt;1
                  x10^9/l)

               -  History of drug-induced hematologic or hepatic abnormalities

          -  Anticipated requirement for long-term (&gt;7 day) non-study antiplatelet drugs (eg,
             dipyridamole, clopidogrel, ticlopidine), or Non-steroidal Anti-inflammatory Drugs
             (NSAIDs) affecting platelet function (such as prior vascular stent or arthritis).

          -  Inability to swallow medications.

          -  At risk for pregnancy: premenopausal or post menopausal woman within 12 months of last
             menses without a negative pregnancy test or not committing to adequate birth control
             (e.g., oral contraceptive, two methods of barrier birth control, or abstinence).

          -  Unavailability for follow-up.

          -  Signed and dated informed consent not obtained from patient.

          -  Other neurological conditions that would complicate assessment of outcomes during
             follow-up.

          -  Ongoing treatment in another study of an investigational therapy that may potentially
             interact with study drug, or treatment in such a study within the last 7 days.

          -  Previously enrolled in the POINT study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>S. Claiborne Johnston, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas, Austin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J. Donald Easton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anthony S. Kim, MD, MAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chandler Regional Medical Center</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner University Medical Center - Tucson Campus</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy San Juan Medical Center</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSD Health La Jolla</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ronald Reagan UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Desert Regional Medical Center</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huntington Memorial Hospital</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Mercy Hospital San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSD Medical Center - Hillcrest Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Los Robles Hospital and Medical Center</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Anthony Hospital</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale-New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>George Washington University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UF Health Shands Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sarasota Memorial Hospital</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University Medical Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>the Queen's Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Medical Center</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evanston Hospital</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore Glenbrook Hospital</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <zip>60026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presence Saint Joseph Medical Center</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Illinois University Memorial Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62781</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth Medical Center South</name>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth Hospital</name>
      <address>
        <city>Florence</city>
        <state>Kentucky</state>
        <zip>41042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth Hospital Fort Thomas</name>
      <address>
        <city>Fort Thomas</city>
        <state>Kentucky</state>
        <zip>41075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Hospital</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frederick Memorial Hospital</name>
      <address>
        <city>Frederick</city>
        <state>Maryland</state>
        <zip>21701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMASS Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Detroit Receiving Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harper University Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai-Grace Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Saint Mary's</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital - Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford West Bloomfield Hospital</name>
      <address>
        <city>West Bloomfield</city>
        <state>Michigan</state>
        <zip>48322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairview Southdale Hospital</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Saint Mary's Campus</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benefis Hospitals Inc</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Falls Clinic Hospital, Great Falls</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>08820</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jersey Shore University Medical Center</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lincoln Medical and Mental Health Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10451</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings County Hospital Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buffalo General Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian / Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYP Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rochester General Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strong Memorial Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guilford Neurologic Associates</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Akron City Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health West Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewish Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bethesda North Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSU Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Carmel East Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Toledo Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Portland Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Portland VA Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hahnemann University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn Presbyterian Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Shadyside Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WellSpan York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina University Hospital</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palmetto Health Richland</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37323</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Brackenridge</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seton Medical Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Presbyterian Hospital - Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Baptist Medical Center - Harlingen</name>
      <address>
        <city>Harlingen</city>
        <state>Texas</state>
        <zip>78550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ben Taub General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UVA Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Francis Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Mary's Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henrico Doctors' Hospital - Forest Campus</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henrico Doctors' Hospital - Parham Campus</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WVU Healthcare Ruby Memorial Hospital</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia St. Mary's Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Froedtert Memorial Lutheran Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gosford Hospital</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Northern Hospital</name>
      <address>
        <city>Epping</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Footscray Hospital</name>
      <address>
        <city>Footscray</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Calgary - Foothills Campus</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grey Nuns Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Center</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charles LeMoyne Hospital</name>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Notre-Dame Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Enfant-Jesus Hospital</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fleyriat Hospital</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pierre Wetheimer Hospital</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adolphe de Rothschild Ophthalmologic Foundation</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bichat-Claude Bernard Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pitie-Salpetriere Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foch Hospital</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurological Clinic Bad Neustadt</name>
      <address>
        <city>Bad Neustadt an der Saale</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Hospital Neukolln</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Bremen Hospital</name>
      <address>
        <city>Bremen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein Kiel Campus</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Munster</name>
      <address>
        <city>Munster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mexican Association for Clinical Research</name>
      <address>
        <city>Pachuca</city>
        <state>Hidalgo</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Hospital Dr. Ignacio Morones Prieto</name>
      <address>
        <city>San Luis PotosÃ­</city>
        <state>San Luis Potosi</state>
        <zip>78240</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Culiacan General Hospital</name>
      <address>
        <city>Culiacan</city>
        <state>Sinaloa</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurosciences Clinical Trials</name>
      <address>
        <city>Culiacan</city>
        <state>Sinaloa</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ABC Medical Center Santa Fe</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Creu and Sant Pau Hospital</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vall d'Hebron Hospital</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Basurto Hospital</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Burgos University Hospital</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Donostia</name>
      <address>
        <city>Donostia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Girona University HOspital</name>
      <address>
        <city>Girona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Fe University Hospital</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miguel Servet Hospital</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Addenbrooke's Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth University Hospital</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwick Park Hospital</name>
      <address>
        <city>Harrow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal London Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Luton and Dunstable University Hospital</name>
      <address>
        <city>Luton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal United Hospital - Bath</name>
      <address>
        <city>Somerset</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Stoke University Hospital</name>
      <address>
        <city>Stoke-on-Trent</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Mexico</country>
    <country>New Zealand</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ovbiagele B. Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale. J Emerg Med. 2008 May;34(4):389-96. doi: 10.1016/j.jemermed.2007.08.056. Epub 2008 Jan 18. Review.</citation>
    <PMID>18207691</PMID>
  </reference>
  <reference>
    <citation>Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007 Dec;6(12):1063-72. Epub 2007 Nov 13. Review.</citation>
    <PMID>17993293</PMID>
  </reference>
  <reference>
    <citation>Kernan WN, Schindler JL. Rapid intervention for TIA: a new standard emerges. Lancet Neurol. 2007 Nov;6(11):940-1.</citation>
    <PMID>17928271</PMID>
  </reference>
  <reference>
    <citation>Rothwell PM. Transient ischaemic attacks: time to wake up. Heart. 2007 Aug;93(8):893-4.</citation>
    <PMID>17639101</PMID>
  </reference>
  <reference>
    <citation>Streifler JY. Early stroke risk after a transient ischemic attack: can it be minimized? Stroke. 2008 Jun;39(6):1655-6. doi: 10.1161/STROKEAHA.107.510248. Epub 2008 Mar 27.</citation>
    <PMID>18369165</PMID>
  </reference>
  <reference>
    <citation>Dean N, Shuaib A. Transient ischaemic attacks: unstable, treatable, neglected. Lancet. 2007 Oct 20;370(9596):1398-400.</citation>
    <PMID>17928045</PMID>
  </reference>
  <reference>
    <citation>Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM; FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007 Nov;6(11):961-9. Epub 2007 Oct 10.</citation>
    <PMID>17931979</PMID>
  </reference>
  <reference>
    <citation>Geisler T, ZÃ¼rn C, Paterok M, GÃ¶hring-Frischholz K, Bigalke B, Stellos K, Seizer P, Kraemer BF, Dippon J, May AE, Herdeg C, Gawaz M. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. Eur Heart J. 2008 Jul;29(13):1635-43. doi: 10.1093/eurheartj/ehn212. Epub 2008 May 24.</citation>
    <PMID>18503057</PMID>
  </reference>
  <reference>
    <citation>Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP; TIMI 22 Investigators. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J. 2008 May;155(5):954-8. doi: 10.1016/j.ahj.2007.12.009. Epub 2008 Feb 19.</citation>
    <PMID>18440347</PMID>
  </reference>
  <reference>
    <citation>Mitsios JV, Papathanasiou AI, Rodis FI, Elisaf M, Goudevenos JA, Tselepis AD. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Circulation. 2004 Mar 23;109(11):1335-8. Epub 2004 Mar 15.</citation>
    <PMID>15023882</PMID>
  </reference>
  <reference>
    <citation>Riondino S, Petrini N, Donato L, Torromeo C, Tanzilli G, Pulcinelli FM, BarillÃ  F. Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients. J Thromb Thrombolysis. 2009 Aug;28(2):151-5. doi: 10.1007/s11239-008-0254-6. Epub 2008 Jul 18.</citation>
    <PMID>18636229</PMID>
  </reference>
  <reference>
    <citation>Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ; CHARISMA Investigators. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol. 2007 Jul 24;50(4):291-5. Epub 2007 Jul 10.</citation>
    <PMID>17659194</PMID>
  </reference>
  <reference>
    <citation>Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation. 2003 Aug 26;108(8):921-4. Epub 2003 Aug 18.</citation>
    <PMID>12925453</PMID>
  </reference>
  <reference>
    <citation>Trenk D, Hochholzer W, Frundi D, Stratz C, Valina CM, Bestehorn HP, BÃ¼ttner HJ, Neumann FJ. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. Thromb Haemost. 2008 Jan;99(1):174-81. doi: 10.1160/TH07-08-0503.</citation>
    <PMID>18217151</PMID>
  </reference>
  <reference>
    <citation>Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000 Dec 13;284(22):2901-6.</citation>
    <PMID>11147987</PMID>
  </reference>
  <reference>
    <citation>Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM; VISION study group. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke. 2008 Feb;3(1):3-10. doi: 10.1111/j.1747-4949.2008.00182.x.</citation>
    <PMID>18705908</PMID>
  </reference>
  <reference>
    <citation>Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol. 2005 Jun;57(6):848-54.</citation>
    <PMID>15929051</PMID>
  </reference>
  <reference>
    <citation>Algra A, van Gijn J, Halkes PH, Kappelle LJ, Koudstaal PJ; ESPRIT Study Group. Interpretation of ESPRIT in the FASTER trial. Lancet Neurol. 2008 Mar;7(3):198-9; author reply 199. doi: 10.1016/S1474-4422(08)70030-9.</citation>
    <PMID>18275919</PMID>
  </reference>
  <reference>
    <citation>LavallÃ©e PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, LesÃ¨che G, Labreuche J, Touboul PJ, Amarenco P. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007 Nov;6(11):953-60.</citation>
    <PMID>17928270</PMID>
  </reference>
  <reference>
    <citation>Luengo-Fernandez R, Gray AM, Rothwell PM. Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol. 2009 Mar;8(3):235-43. doi: 10.1016/S1474-4422(09)70019-5. Epub 2009 Feb 4.</citation>
    <PMID>19200786</PMID>
  </reference>
  <reference>
    <citation>Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, DahlÃ¶f B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.</citation>
    <PMID>18753639</PMID>
  </reference>
  <reference>
    <citation>Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, DahlÃ¶f B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.</citation>
    <PMID>18753638</PMID>
  </reference>
  <reference>
    <citation>Brown RD Jr, Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke. 1998 Oct;29(10):2109-13.</citation>
    <PMID>9756590</PMID>
  </reference>
  <reference>
    <citation>Kissela B, Broderick J, Woo D, Kothari R, Miller R, Khoury J, Brott T, Pancioli A, Jauch E, Gebel J, Shukla R, Alwell K, Tomsick T. Greater Cincinnati/Northern Kentucky Stroke Study: volume of first-ever ischemic stroke among blacks in a population-based study. Stroke. 2001 Jun;32(6):1285-90.</citation>
    <PMID>11387488</PMID>
  </reference>
  <reference>
    <citation>Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999 Dec;30(12):2523-8.</citation>
    <PMID>10582972</PMID>
  </reference>
  <reference>
    <citation>Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, Schneider A, Alwell K, Jauch E, Miller R, Moomaw C, Shukla R, Broderick JP. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005 Apr;36(4):720-3. Epub 2005 Feb 24.</citation>
    <PMID>15731465</PMID>
  </reference>
  <reference>
    <citation>Edlow JA, Kim S, Pelletier AJ, Camargo CA Jr. National study on emergency department visits for transient ischemic attack, 1992-2001. Acad Emerg Med. 2006 Jun;13(6):666-72. Epub 2006 Apr 11.</citation>
    <PMID>16609106</PMID>
  </reference>
  <reference>
    <citation>Howard G, Toole JF, Frye-Pierson J, Hinshelwood LC. Factors influencing the survival of 451 transient ischemic attack patients. Stroke. 1987 May-Jun;18(3):552-7.</citation>
    <PMID>3590245</PMID>
  </reference>
  <reference>
    <citation>Shah KH, Kleckner K, Edlow JA. Short-term prognosis of stroke among patients diagnosed in the emergency department with a transient ischemic attack. Ann Emerg Med. 2008 Mar;51(3):316-23. doi: 10.1016/j.annemergmed.2007.08.016. Epub 2007 Oct 25. Review. Erratum in: Ann Emerg Med. 2008 Jun;51(6):774.</citation>
    <PMID>18282526</PMID>
  </reference>
  <reference>
    <citation>Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med. 2007 Dec 10;167(22):2417-22. Review.</citation>
    <PMID>18071162</PMID>
  </reference>
  <reference>
    <citation>Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JV. Management and outcomes of transient ischemic attacks in Ontario. CMAJ. 2004 Mar 30;170(7):1099-104.</citation>
    <PMID>15051693</PMID>
  </reference>
  <reference>
    <citation>Lisabeth LD, Ireland JK, Risser JM, Brown DL, Smith MA, Garcia NM, Morgenstern LB. Stroke risk after transient ischemic attack in a population-based setting. Stroke. 2004 Aug;35(8):1842-6. Epub 2004 Jun 10.</citation>
    <PMID>15192239</PMID>
  </reference>
  <reference>
    <citation>Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ; North American Symptomatic Carotid Endarterectomy Trial Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004 Mar 30;170(7):1105-9.</citation>
    <PMID>15051694</PMID>
  </reference>
  <reference>
    <citation>Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004 Jun 8;62(11):2015-20.</citation>
    <PMID>15184607</PMID>
  </reference>
  <reference>
    <citation>Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005 Jul 2-8;366(9479):29-36.</citation>
    <PMID>15993230</PMID>
  </reference>
  <reference>
    <citation>Lovett JK, Dennis MS, Sandercock PA, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after a first transient ischemic attack. Stroke. 2003 Aug;34(8):e138-40. Epub 2003 Jul 10.</citation>
    <PMID>12855835</PMID>
  </reference>
  <reference>
    <citation>Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB, Christenson RH, Hasselblad V, Stebbins A, McNulty S, Newby LK. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol. 2003 Apr 15;91(8):936-40.</citation>
    <PMID>12686331</PMID>
  </reference>
  <reference>
    <citation>Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973 Mar;48(3):194-8.</citation>
    <PMID>4690325</PMID>
  </reference>
  <reference>
    <citation>Humphrey PR, Marshall J. Transient ischemic attacks and strokes with recovery prognosis and investigation. Stroke. 1981 Nov-Dec;12(6):765-9.</citation>
    <PMID>7303066</PMID>
  </reference>
  <reference>
    <citation>Putman SF, Adams HP Jr. Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol. 1985 Oct;42(10):960-2.</citation>
    <PMID>4038103</PMID>
  </reference>
  <reference>
    <citation>Biller J, Bruno A, Adams HP Jr, Godersky JC, Loftus CM, Mitchell VL, Banwart KJ, Jones MP. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Stroke. 1989 Apr;20(4):441-7.</citation>
    <PMID>2648650</PMID>
  </reference>
  <reference>
    <citation>Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990 Jun;21(6):848-53.</citation>
    <PMID>2349586</PMID>
  </reference>
  <reference>
    <citation>Coull AJ, Lovett JK, Rothwell PM; Oxford Vascular Study. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004 Feb 7;328(7435):326. Epub 2004 Jan 26.</citation>
    <PMID>14744823</PMID>
  </reference>
  <reference>
    <citation>Daffertshofer M, Mielke O, Pullwitt A, Felsenstein M, Hennerici M. Transient ischemic attacks are more than &quot;ministrokes&quot;. Stroke. 2004 Nov;35(11):2453-8. Epub 2004 Oct 14.</citation>
    <PMID>15486333</PMID>
  </reference>
  <reference>
    <citation>Whitehead MA, McManus J, McAlpine C, Langhorne P. Early recurrence of cerebrovascular events after transient ischaemic attack. Stroke. 2005 Jan;36(1):1; author reply 1.</citation>
    <PMID>15618448</PMID>
  </reference>
  <reference>
    <citation>Correia M, Silva MR, MagalhÃ£es R, GuimarÃ£es L, Silva MC. Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke. 2006 Jan;37(1):50-5. Epub 2005 Dec 1.</citation>
    <PMID>16322498</PMID>
  </reference>
  <reference>
    <citation>Purroy F, Molina CA, Montaner J, Alvarez-SabÃ­n J. Absence of usefulness of ABCD score in the early risk of stroke of transient ischemic attack patients. Stroke. 2007 Mar;38(3):855-6; author reply 857. Epub 2007 Jan 18.</citation>
    <PMID>17234986</PMID>
  </reference>
  <reference>
    <citation>Wang Y, Johnston SC; CHANCE Investigators. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010 Sep;160(3):380-386.e1. doi: 10.1016/j.ahj.2010.05.017.</citation>
    <PMID>20826243</PMID>
  </reference>
  <reference>
    <citation>Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 Jul 4;369(1):11-9. doi: 10.1056/NEJMoa1215340. Epub 2013 Jun 26.</citation>
    <PMID>23803136</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>October 6, 2009</study_first_submitted>
  <study_first_submitted_qc>October 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2009</study_first_posted>
  <results_first_submitted>October 4, 2018</results_first_submitted>
  <results_first_submitted_qc>November 14, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 4, 2018</results_first_posted>
  <last_update_submitted>November 14, 2018</last_update_submitted>
  <last_update_submitted_qc>November 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transient Ischemic Attack</keyword>
  <keyword>TIA</keyword>
  <keyword>minor stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT00991029/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 30, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT00991029/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Clopidogrel</title>
          <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2432"/>
                <participants group_id="P2" count="2449"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2276"/>
                <participants group_id="P2" count="2281"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="168"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Clopidogrel</title>
          <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2432"/>
            <count group_id="B2" value="2449"/>
            <count group_id="B3" value="4881"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age at time of randomization</description>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.0" lower_limit="55.0" upper_limit="74.0"/>
                    <measurement group_id="B2" value="65.0" lower_limit="56.0" upper_limit="74.0"/>
                    <measurement group_id="B3" value="65.0" lower_limit="55.0" upper_limit="74.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1097"/>
                    <measurement group_id="B2" value="1098"/>
                    <measurement group_id="B3" value="2195"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1335"/>
                    <measurement group_id="B2" value="1351"/>
                    <measurement group_id="B3" value="2686"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <description>Race or ethnic group was determined by the investigator. Hispanic ethnic group was assessed only in patients in the United States.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="290"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2176"/>
                    <measurement group_id="B2" value="2182"/>
                    <measurement group_id="B3" value="4358"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="112"/>
                    <measurement group_id="B2" value="121"/>
                    <measurement group_id="B3" value="233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="144"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="473"/>
                    <measurement group_id="B2" value="493"/>
                    <measurement group_id="B3" value="966"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1774"/>
                    <measurement group_id="B2" value="1781"/>
                    <measurement group_id="B3" value="3555"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>New Zealand</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2014"/>
                    <measurement group_id="B2" value="2029"/>
                    <measurement group_id="B3" value="4043"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mexico</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="122"/>
                    <measurement group_id="B3" value="241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Qualifying Event</title>
          <description>TIA or Ischemic Stroke</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2432"/>
                    <count group_id="B2" value="2449"/>
                    <count group_id="B3" value="4881"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>TIA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1056"/>
                    <measurement group_id="B2" value="1052"/>
                    <measurement group_id="B3" value="2108"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Ischemic Stroke</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1376"/>
                    <measurement group_id="B2" value="1397"/>
                    <measurement group_id="B3" value="2773"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Qualifying Neurologic Score</title>
          <description>The ABCD2 score is a seven-point score for identifying patients who have suffered a transient ischemic attack (TIA) at the highest risk of stroke (scores ranges from 0 to 7, with higher scores indicating a greater risk of stroke).
The National Institutes of Health Stroke Scale (NIHSS) score is used quantify the impairment caused by a stroke (scores range from 0 to 42, with higher scores indicating greater stroke severity).
Patients were eligible if they had an acute ischemic stroke with a score of 3 or less on the NIHSS or had a TIA with a score of 4 or more on the ABCD2 scale.</description>
          <population>ABCD2 scores were available for 2104 of the 2108 patients with TIA (1055 patients in the clopidogrel group and 1049 in the placebo group). NIHSS scores were available for 2750 of the 2773 patients with ischemic stroke (1365 patients in the clopidogrel group and 1385 in the aspirin group).</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>ABCD2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1055"/>
                    <count group_id="B2" value="1049"/>
                    <count group_id="B3" value="2104"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.0" lower_limit="4.0" upper_limit="6.0"/>
                    <measurement group_id="B2" value="5.0" lower_limit="4.0" upper_limit="5.0"/>
                    <measurement group_id="B3" value="5.0" lower_limit="4.0" upper_limit="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>National Institutes of Health Stroke Scale</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1365"/>
                    <count group_id="B2" value="1385"/>
                    <count group_id="B3" value="2750"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.0" lower_limit="1.0" upper_limit="2.0"/>
                    <measurement group_id="B2" value="2.0" lower_limit="1.0" upper_limit="2.0"/>
                    <measurement group_id="B3" value="2.0" lower_limit="1.0" upper_limit="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes</title>
        <description>Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes</title>
          <description>Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.75</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.59</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Major Hemorrhage</title>
        <description>Primary safety outcome: Number of Participants with major hemorrhage</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Major Hemorrhage</title>
          <description>Primary safety outcome: Number of Participants with major hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>2.32</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.10</ci_lower_limit>
            <ci_upper_limit>4.87</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ischemic Stroke</title>
        <description>Secondary efficacy outcome:Number of participants with Ischemic stroke</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Ischemic Stroke</title>
          <description>Secondary efficacy outcome:Number of participants with Ischemic stroke</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                    <measurement group_id="O2" value="155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.56</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Myocardial Infarction</title>
        <description>Secondary efficacy outcome: Number of participants with Myocardial infarction</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Myocardial Infarction</title>
          <description>Secondary efficacy outcome: Number of participants with Myocardial infarction</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.46</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.44</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.55</ci_lower_limit>
            <ci_upper_limit>3.78</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Ischemic Vascular Causes</title>
        <description>Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Ischemic Vascular Causes</title>
          <description>Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.52</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.51</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.43</ci_lower_limit>
            <ci_upper_limit>5.35</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ischemic or Hemorrhagic Stroke</title>
        <description>Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Ischemic or Hemorrhagic Stroke</title>
          <description>Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                    <measurement group_id="O2" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Ischemic Stroke, Myocardial Infarction, Death From Ischemic Vascular Causes, or Major Hemorrhage</title>
        <description>Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage</description>
        <time_frame>Up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Ischemic Stroke, Myocardial Infarction, Death From Ischemic Vascular Causes, or Major Hemorrhage</title>
          <description>Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141"/>
                    <measurement group_id="O2" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.67</ci_lower_limit>
            <ci_upper_limit>1.05</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Hemorrhagic Stroke</title>
        <description>Other safety outcome: Number of participants with Hemorrhagic stroke</description>
        <time_frame>up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Hemorrhagic Stroke</title>
          <description>Other safety outcome: Number of participants with Hemorrhagic stroke</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.47</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.68</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.4</ci_lower_limit>
            <ci_upper_limit>7.03</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Symptomatic Intracerebral Hemorrhage</title>
        <description>Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage</description>
        <time_frame>up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Symptomatic Intracerebral Hemorrhage</title>
          <description>Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.99</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.14</ci_lower_limit>
            <ci_upper_limit>7.14</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Other Symptomatic Intracranial Hemorrhage</title>
        <description>Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage</description>
        <time_frame>up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Other Symptomatic Intracranial Hemorrhage</title>
          <description>Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Major Hemorrhage Other Than Intracranial Hemorrhage</title>
        <description>Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage</description>
        <time_frame>up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Major Hemorrhage Other Than Intracranial Hemorrhage</title>
          <description>Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>2.45</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.01</ci_lower_limit>
            <ci_upper_limit>5.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Minor Hemorrhage</title>
        <description>Other safety outcome:Number of Participants with Minor hemorrhage</description>
        <time_frame>up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Minor Hemorrhage</title>
          <description>Other safety outcome:Number of Participants with Minor hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>3.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.67</ci_lower_limit>
            <ci_upper_limit>5.83</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Death From Any Cause</title>
        <description>Other safety outcome: Number of Participants with Death from any cause</description>
        <time_frame>up to 90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clopidogrel</title>
            <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Any Cause</title>
          <description>Other safety outcome: Number of Participants with Death from any cause</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2432"/>
                <count group_id="O2" value="2449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.27</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.51</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.73</ci_lower_limit>
            <ci_upper_limit>3.13</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>90 days from randomization</time_frame>
      <desc>Only serious adverse events or protocol-defined clinical outcomes were collected (not all non-serious adverse events). The clinical outcomes also have been reported under the outcomes section.
Some, but not all, non-serious adverse events were collected and they are included in the 'Other (not including serious) Adverse Events' table below.</desc>
      <group_list>
        <group group_id="E1">
          <title>Clopidogrel</title>
          <description>Patients assigned to clopidogrel in addition to aspirin
Clopidogrel: Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Patients assigned to placebo in addition to aspirin
placebo: Loading dose of 8 tablets followed by one tablet daily for 89 days</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 15.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2432"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="382" subjects_at_risk="2432"/>
                <counts group_id="E2" subjects_affected="382" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="2432"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Heart valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis fugax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Implant site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Meningitis leptospiral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Neurosyphilis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspiration bronchial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Arthritis reactive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Carotid body tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Metastases to meninges</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Carotid artery dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="2432"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Central nervous system lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebral artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebral venous thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="2432"/>
                <counts group_id="E2" events="24" subjects_affected="22" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Complex partial seizures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Complicated migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="2432"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Diabetic hyperglycaemic coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Intracranial haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="83" subjects_affected="82" subjects_at_risk="2432"/>
                <counts group_id="E2" events="118" subjects_affected="113" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Optic neuritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Reversible ischaemic neurological deficit</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="54" subjects_affected="49" subjects_at_risk="2432"/>
                <counts group_id="E2" events="62" subjects_affected="55" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Acute psychosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Acute stress disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Conversion disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dysthymic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Somatisation disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Nasal cavity mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arterial repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Carotid artery stent insertion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Carotid endarterectomy</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2432"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Coronary revascularisation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Drug rehabilitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Endarterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Intra-cerebral aneurysm operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Nephrectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Rotator cuff repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Toe amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Subclavian steal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 15.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="89" subjects_at_risk="2432"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral amyloid angiopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="2432"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="43" subjects_affected="40" subjects_at_risk="2432"/>
                <counts group_id="E2" events="46" subjects_affected="42" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysfunctional uterine bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2432"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2449"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2432"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2432"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2449"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jordan Elm</name_or_title>
      <organization>Medical University of South Carolina</organization>
      <phone>843-876-1605</phone>
      <email>elmj@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

